Barbara Lupo

1.3k total citations
20 papers, 420 citations indexed

About

Barbara Lupo is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Barbara Lupo has authored 20 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Hematology. Recurrent topics in Barbara Lupo's work include Colorectal Cancer Treatments and Studies (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Barbara Lupo is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Barbara Lupo collaborates with scholars based in Italy, Belgium and United States. Barbara Lupo's co-authors include Livio Trusolino, Cristina Tringali, Bruno Venerando, Guido Tettamanti, Nadia Papini, Luigi Anastasia, Andrea Bertotti, Paolo M. Comoglio, Francesco Sassi and Francesca Cottino and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Barbara Lupo

18 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Lupo Italy	10	281	185	82	68	58	20	420
Janice M. Mehnert United States	8	303 1.1×	183 1.0×	52 0.6×	58 0.9×	28 0.5×	24	409
Vivien N. Jacobs United Kingdom	11	290 1.0×	194 1.0×	50 0.6×	53 0.8×	37 0.6×	18	504
Kristiaan Lenos Netherlands	14	342 1.2×	237 1.3×	75 0.9×	169 2.5×	47 0.8×	27	517
Gina M. Ney United States	12	273 1.0×	82 0.4×	102 1.2×	82 1.2×	74 1.3×	19	438
Mary Flanagan Quinn United States	6	284 1.0×	173 0.9×	42 0.5×	33 0.5×	43 0.7×	12	381
Roel H. Wilting Netherlands	4	443 1.6×	130 0.7×	41 0.5×	86 1.3×	26 0.4×	4	547
Sho Kubota Japan	16	369 1.3×	122 0.7×	65 0.8×	80 1.2×	74 1.3×	46	552
Shaokun Shu China	11	330 1.2×	208 1.1×	108 1.3×	167 2.5×	36 0.6×	18	575
Danny Rickwood Australia	11	427 1.5×	208 1.1×	55 0.7×	122 1.8×	77 1.3×	13	598
Florian Schelter Germany	11	259 0.9×	192 1.0×	125 1.5×	140 2.1×	22 0.4×	19	495

Countries citing papers authored by Barbara Lupo

Since Specialization

Citations

This map shows the geographic impact of Barbara Lupo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Lupo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Lupo more than expected).

Fields of papers citing papers by Barbara Lupo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Lupo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Lupo. The network helps show where Barbara Lupo may publish in the future.

Co-authorship network of co-authors of Barbara Lupo

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Lupo. A scholar is included among the top collaborators of Barbara Lupo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Lupo. Barbara Lupo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boidot, Romain, Bernhard Drotleff, Bart Ghesquière, et al.. (2025). Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers. Cancer Letters. 613. 217512–217512.

Ganci, Federica, Andrea Sacconi, Matteo Allegretti, et al.. (2024). Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 234–234. 3 indexed citations

Beekhof, Robin, Andrea Bertotti, Franziska Böttger, et al.. (2023). Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer. Science Translational Medicine. 15(709). eabm3687–eabm3687. 17 indexed citations

Grassi, Elena, Barbara Lupo, Diego Pasini, et al.. (2023). Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity. Genome Medicine. 15(1). 37–37. 8 indexed citations

Brammeld, Jonathan, Mar Arias-García, Stacey Price, et al.. (2021). Abstract 1081: Genome-wide CRISPR screens reveal Hippo pathway activation as a resistance mechanism in BRAF mutant colon cancer. Cancer Research. 81(13_Supplement). 1081–1081. 2 indexed citations

Lupo, Barbara, Francesco Sassi, Marika Pinnelli, et al.. (2018). PO-049 EGFR blockade induces a paneth cell-like phenotype with rewired signalling dependencies in CRC tumoursat maximal response. ESMO Open. 3. A246–A247.

Lupo, Barbara, Paolo Armando Gagliardi, Francesco Sassi, et al.. (2017). Abstract LB-293: Targeting the PI3K pathway to intercept cetuximab tolerance in metastatic colorectal cancer. Cancer Research. 77(13_Supplement). LB–293. 1 indexed citations

Pupo, Emanuela, Barbara Lupo, Elisa Vigna, et al.. (2016). Rebound Effects Caused by Withdrawal of MET Kinase Inhibitor Are Quenched by a MET Therapeutic Antibody. Cancer Research. 76(17). 5019–5029. 20 indexed citations

Lupo, Barbara, Jorge Vialard, Francesco Sassi, et al.. (2016). Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals. BMC Biology. 14(1). 5–5. 19 indexed citations

10.

Lupo, Barbara, Jorge Vialard, Andrea Bertotti, Letizia Lanzetti, & Livio Trusolino. (2015). Abstract 4148: Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals. Cancer Research. 75(15_Supplement). 4148–4148. 1 indexed citations

11.

Zanella, Eugenia R., Francesco Galimi, Francesco Sassi, et al.. (2015). IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. Science Translational Medicine. 7(272). 272ra12–272ra12. 70 indexed citations

12.

Testa, Francesca, Roberta Zappasodi, Christopher W. Cairo, et al.. (2014). Sialidase NEU4 is involved in glioblastoma stem cell survival. Cell Death and Disease. 5(8). e1381–e1381. 25 indexed citations

13.

Lupo, Barbara & Livio Trusolino. (2014). Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846(1). 201–215. 108 indexed citations

14.

Tringali, Cristina, Federica Cirillo, Giuseppe Lamorte, et al.. (2012). NEU4L sialidase overexpression promotes β‐catenin signaling in neuroblastoma cells, enhancing stem‐like malignant cell growth. International Journal of Cancer. 131(8). 1768–1778. 22 indexed citations

15.

Cavallo, Federica, et al.. (2012). Treatment of Relapsed or Refractory Multiple Myeloma in the Era of Novel Agents. European Oncology & Haematology. 8(2). 116–116. 1 indexed citations

16.

Tringali, Cristina, Barbara Lupo, Nadia Papini, et al.. (2012). The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling β1 Integrin Internalization and Recycling. Journal of Biological Chemistry. 287(51). 42835–42845. 55 indexed citations

17.

Lupo, Barbara & Antonio Palumbo. (2012). Lenalidomide in the Treatment of Young Patients with Multiple Myeloma: From Induction to Consolidation/Maintenance Therapy. Advances in Hematology. 2012. 1–6. 1 indexed citations

18.

Boccadoro, Mario, Federica Cavallo, A. Nagler, et al.. (2011). Melphalan/prednisone/lenalidomide (MPR) versus high-dose melphalan and autologous transplantation (MEL200) in newly diagnosed multiple myeloma (MM) patients: A phase III trial.. Journal of Clinical Oncology. 29(15_suppl). 8020–8020. 13 indexed citations

19.

Cavallo, Federica, Francesco Di Raimondo, Barbara Lupo, et al.. (2010). A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen.. Blood. 116(21). 1092–1092. 8 indexed citations

20.

Tringali, Cristina, Barbara Lupo, Luigi Anastasia, et al.. (2007). Expression of Sialidase Neu2 in Leukemic K562 Cells Induces Apoptosis by Impairing Bcr-Abl/Src Kinases Signaling. Journal of Biological Chemistry. 282(19). 14364–14372. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact